Welcome to our dedicated page for Novanta news (Ticker: NOVT), a resource for investors and traders seeking the latest updates and insights on Novanta stock.
Novanta Inc. reports developments as a Nasdaq-listed supplier of core technology solutions for medical, life science and advanced industrial original equipment manufacturers. Its updates center on precision medicine, precision manufacturing, robotics and automation, and advanced surgery, including laser beam steering and scanning, laser sources, robotic and precision motion technologies, medical insufflators, endoscopic pumps and integrated operating room technologies.
Company news commonly covers quarterly earnings releases, conference calls, investor presentations, OEM design wins, product and technology collaborations, and capital actions tied to balance-sheet and securities structure. Recent themes include motion control and sensing technologies for robotics certification environments and tangible equity unit financing.
Novanta Inc. (Nasdaq: NOVT) announces that CEO Matthijs Glastra and CFO Robert Buckley will present at the Baird Global Industrial Conference on November 11, 2020. The company is renowned for providing core technology solutions, enhancing the competitive edge of medical and industrial OEMs through expertise in photonics, vision, and precision motion. Novanta's common shares are listed on Nasdaq under the ticker symbol 'NOVT'. For more details, visit www.novanta.com.
Novanta Inc. (Nasdaq: NOVT) will release its third quarter 2020 results on November 10, 2020. A conference call to discuss these results is scheduled for the same day at 10:00 a.m. ET. Investors can join by dialing (888) 346-3959 or through a live webcast on the company’s Investor Relations page. A replay of the call will be available three hours post-conclusion until January 4, 2020.
Novanta specializes in technology solutions for healthcare and industrial OEMs.